EUVIMEDEUVIMED entdecken
Crossref

Porphyromonas gingivalis triggers inflammation in hepatocyte depend on ferroptosis via activating the NF‐κB signaling pathway

Chao Yao iD, Dongmei Lan, Xue Li, Yan Wang, Shengcai Qi iD

Oral Diseases · 2024-04 · 30 (3) · 1680-1694

DOI: 10.1111/odi.14537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, online erschienen am 05.04.2023. Verfasst von Chao Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical College, Anhui University of Science and Technology, Huainan, China. Hauptthemen laut MEDLINE: Porphyromonas gingivalis, NF-kappa B, Hepatocytes, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: foundation of Shanghai Municipal Health Commission, foundation of Shanghai Stomatological Hospital, Nature Science foundation of Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Non‐alcoholic fatty liver disease (NAFLD) is a clinicopathological syndrome characterized by excessive fat deposition in hepatocytes caused by non‐alcoholic liver injury. Porphyromonas gingivalis ( P.g ) is the main pathogen causing periodontitis, which can aggravate the progression of NAFLD in our previously study. The objective of this study was to further investigate the pathogenesis and moleculer michanisma of NAFLD aggravated by P.g .

Methods

A mouse model of NAFLD was established, and the changes of inflammatory factors and NF‐κB signaling pathway in liver tissue and L‐02 cells were analyzed by transcriptome sequencing, Western blot, IHC and RT‐PCR. In addition, the NF‐κB signaling pathway inhibitor QNZ and ferroptosis inhibitor Fer‐1 were used to analyze the relationship between NF‐κB signaling pathway and ferroptosis in vitro.

Results

In vivo and in vitro experiments, P.g can induce liver inflammation and activate NF‐κB signaling pathway. At the same time, P.g promotes ferroptosis and inflammation in L‐02 in vitro. QNZ alleviates ferroptosis and inflammatory activation in L‐02. Fer‐1 can relieve the L‐02 inflammation caused by P.g products .

Conclusion

Porphyromonas gingivalis can induce ferroptosis and inflammation in hepatocytes and further worsen liver lesions. The mechanism of ferroptosis in hepatocytes depends on NF‐κB signaling pathway, which provides a new strategy for clinical treatment and prevention of NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porphyromonas gingivalisNF-kappa BHepatocytesNon-alcoholic Fatty Liver DiseaseSignal TransductionFerroptosisAnimalsMiceInflammationMaleMice, Inbred C57BLHumansDisease Models, AnimalBacteroidaceae InfectionsCell Line

Stichwörter der Autor:innen

Porphyromonas gingivalisNAFLDNF‐κB signaling pathwayferroptosis

Substanzen

NF-kappa B

Autor:innen und Institutionen

  • Medical College, Anhui University of Science and Technology, Huainan, China.
  • Department of Prothodontics, Shanghai Stomatological Hospital, Fudan University, Shanghai, China.
  • Shanghai Key Laboratory of Craniomaxillofacial Development and Diseases, Fudan University, Shanghai, China.

ORCID-Profile: Chao Yao, Shengcai Qi

Förderung

  • foundation of Shanghai Municipal Health Commission
  • foundation of Shanghai Stomatological Hospital
  • Nature Science foundation of Shanghai
  • Shanghai Municipal Health Commission

Zitieren

APA

Yao, C., Lan, D., Li, X., Wang, Y., & Qi, S. (2024). Porphyromonas gingivalis triggers inflammation in hepatocyte depend on ferroptosis via activating the NF‐κB signaling pathway. Oral Diseases, 30(3), 1680-1694. https://doi.org/10.1111/odi.14537

Vancouver

Yao C, Lan D, Li X, Wang Y, Qi S. Porphyromonas gingivalis triggers inflammation in hepatocyte depend on ferroptosis via activating the NF‐κB signaling pathway. Oral Diseases. 2024;30(3):1680-1694. doi:10.1111/odi.14537

BibTeX
@article{Yao2024,
  author = {Yao, Chao and Lan, Dongmei and Li, Xue and Wang, Yan and Qi, Shengcai},
  title = {Porphyromonas gingivalis triggers inflammation in hepatocyte depend on ferroptosis via activating the NF‐κB signaling pathway},
  journal = {Oral Diseases},
  year = {2024},
  volume = {30},
  number = {3},
  pages = {1680--1694},
  doi = {10.1111/odi.14537}
}
Kostenlos starten →